Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma as the company initiates Phase 2 clinical studies of Ratutrelvir (TRX01), a next-generation ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapiesTopline safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback